GT
Genetic Technologies
GENE
ASX - ALL MARKETSHealth Care
Income Statement
Total Revenue$21.32M
Gross Profit$10.81M
Operating Income$-37.48M
EBITDA$-32.12M
EBIT$-32.12M
Pre-tax Income$-21.37M
Net Income$-32.14M
Balance Sheet
Net Cash$10.13M
Cash Equivalent$1.14M
Total Debt$502.61K
Net Debt$-9.63M
Book Value$1.74M
Net Cash Per Share0.07
Book Value Per Share0.02
Key Ratios
Return on Equity (ROE)-656.53%
Return on Assets (ROA)-194.25%
Return on Invested Capital (ROI)-444.16%
Net Profit Margin-156.78%
Current Ratio0.88
Quick Ratio0.75
Long-Term Debt / Equity0.00